After the inaugural posting, FDA Commissioner Andrew C. von Eschenbach has posted a first substantive note on his new space on the FDA Web site. One doesn’t know quite what to label "Andy’s Take". It is a sort of column … Continue reading
For a while now, I’ve been thinking about the growing number of drugs that are being approved overseas and going on the market overseas, but are not getting approved or are getting approvable letters in the U.S. It is a … Continue reading
Yesterday you were able to hear from a former FDA Commissioner Dr. David Kessler. Today, you can hear from the current commissioner. On the FDA Web site, a new element has been added called "Andy’s Take" and it is a … Continue reading
Last week, my employer – Fleishman-Hillard, held a public affairs briefing in Washington, D.C. that included several of the members of the International Advisory Board (IAB) for the firm. The event was co-hosted by the Capitol Hill newspaper Roll Call … Continue reading
Well, Congress was away this week, so the city was less crowded and altogether more pleasant. The drive to work – a dream. Spring sprang on Thursday. I was very busy this week and am very much looking forward to … Continue reading
